X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Novartis with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs TEVA PHARMA (Israel) - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NOVARTIS   TEVA PHARMA
EQUITY SHARE DATA
    NOVARTIS
Mar-17
TEVA PHARMA
Dec-13
NOVARTIS/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs8552,832-   
Low Rs6662,460-   
Sales per share (Unadj.) Rs219.01,625.1-  
Earnings per share (Unadj.) Rs19.1101.5-  
Cash flow per share (Unadj.) Rs20.3232.9-  
Dividends per share (Unadj.) Rs10.0088.87-  
Dividend yield (eoy) %1.33.4 39.2%  
Book value per share (Unadj.) Rs307.01,805.2-  
Shares outstanding (eoy) m29.96848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.51.6 213.2%   
Avg P/E ratio x39.826.1 152.7%  
P/CF ratio (eoy) x37.511.4 329.7%  
Price / Book Value ratio x2.51.5 169.0%  
Dividend payout %52.487.5 59.8%   
Avg Mkt Cap Rs m22,7792,243,604 1.0%   
No. of employees `0000.744.9 1.5%   
Total wages/salary Rs m1,3930-   
Avg. sales/employee Rs Th9,736.230,662.0 31.8%   
Avg. wages/employee Rs Th2,066.80-   
Avg. net profit/employee Rs Th849.01,915.4 44.3%   
INCOME DATA
Net Sales Rs m6,5621,378,102 0.5%  
Other income Rs m7020-   
Total revenues Rs m7,2641,378,102 0.5%   
Gross profit Rs m259377,394 0.1%  
Depreciation Rs m36111,393 0.0%   
Interest Rs m727,068 0.0%   
Profit before tax Rs m917238,932 0.4%   
Minority Interest Rs m01,085 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-156,846 0.0%   
Tax Rs m345-2,917 -11.8%   
Profit after tax Rs m57286,089 0.7%  
Gross profit margin %3.927.4 14.4%  
Effective tax rate %37.6-1.2 -3,081.4%   
Net profit margin %8.76.2 139.6%  
BALANCE SHEET DATA
Current assets Rs m9,731930,765 1.0%   
Current liabilities Rs m1,830811,706 0.2%   
Net working cap to sales %120.48.6 1,393.6%  
Current ratio x5.31.1 463.6%  
Inventory Days Days4991 53.6%  
Debtors Days Days2596 26.2%  
Net fixed assets Rs m57450,118 0.0%   
Share capital Rs m1413,392 4.1%   
"Free" reserves Rs m9,0560-   
Net worth Rs m9,1961,530,810 0.6%   
Long term debt Rs m0704,654 0.0%   
Total assets Rs m11,4993,149,404 0.4%  
Interest coverage x128.49.8 1,306.6%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.60.4 130.4%   
Return on assets %5.03.6 140.2%  
Return on equity %6.25.6 110.6%  
Return on capital %10.14.9 203.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,6050-   
CASH FLOW
From Operations Rs m-380219,598 -0.2%  
From Investments Rs m4,208-77,812 -5.4%  
From Financial Activity Rs m-3,318-263,423 1.3%  
Net Cashflow Rs m510-121,637 -0.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 67.84 Rs / USD

Compare NOVARTIS With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare NOVARTIS With: LUPIN LTD  FULFORD INDIA  ELDER PHARMA  ORCHID PHARMA LTD  SUN PHARMA  



Today's Market

Sensex Opens Flat; Metal Stocks Down(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.9% while the Hang Seng is down 0.1%.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jun 22, 2018 12:21 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS